Annual SGA
$11.89 M
-$1.44 M-10.82%
December 1, 2024
Summary
- As of March 10, 2025, ALDX annual SGA is $11.89 million, with the most recent change of -$1.44 million (-10.82%) on December 1, 2024.
- During the last 3 years, ALDX annual SGA has risen by +$609.20 thousand (+5.40%).
- ALDX annual SGA is now -22.65% below its all-time high of $15.37 million, reached on December 31, 2022.
Performance
ALDX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.95 M
-$1.75 M-47.30%
December 1, 2024
Summary
- As of March 10, 2025, ALDX quarterly SGA is $1.95 million, with the most recent change of -$1.75 million (-47.30%) on December 1, 2024.
- Over the past year, ALDX quarterly SGA has stayed the same.
- ALDX quarterly SGA is now -65.01% below its all-time high of $5.57 million, reached on March 31, 2023.
Performance
ALDX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.71 B
-$55.85 M-3.38%
December 1, 2024
Summary
- As of March 10, 2025, ALDX TTM SGA is -$1.71 billion, with the most recent change of -$55.85 million (-3.38%) on December 1, 2024.
- Over the past year, ALDX TTM SGA has dropped by -$1.72 billion (-14444.81%).
- ALDX TTM SGA is now -3036.80% below its all-time high of -$54.38 million.
Performance
ALDX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ALDX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.8% | 0.0% | -10000.0% |
| 3 y3 years | +5.4% | -24.0% | -10000.0% |
| 5 y5 years | -2.2% | -39.4% | -10000.0% |
ALDX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.6% | +5.4% | -65.0% | +8.2% | -57.2% | at low |
| 5 y | 5-year | -22.6% | +19.1% | -65.0% | +8.2% | -141.2% | at low |
| alltime | all time | -22.6% | +1744.0% | -65.0% | +9495.1% | -3036.8% | at low |
Aldeyra Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $11.89 M(-10.8%) | $1.95 M(-47.3%) | $11.89 M(+1.3%) |
| Sep 2024 | - | $3.70 M(+21.7%) | $11.74 M(+10.4%) |
| Jun 2024 | - | $3.04 M(-5.4%) | $10.64 M(-3.1%) |
| Mar 2024 | - | $3.21 M(+78.4%) | $10.98 M(-17.7%) |
| Dec 2023 | $13.34 M(-13.3%) | $1.80 M(-30.5%) | $13.34 M(-18.0%) |
| Sep 2023 | - | $2.59 M(-23.4%) | $16.27 M(-3.9%) |
| Jun 2023 | - | $3.38 M(-39.3%) | $16.93 M(+1.4%) |
| Mar 2023 | - | $5.57 M(+17.6%) | $16.69 M(+8.6%) |
| Dec 2022 | $15.37 M(+36.3%) | $4.74 M(+45.9%) | $15.37 M(+16.5%) |
| Sep 2022 | - | $3.24 M(+3.2%) | $13.20 M(+5.6%) |
| Jun 2022 | - | $3.14 M(-26.0%) | $12.50 M(+0.6%) |
| Mar 2022 | - | $4.25 M(+65.8%) | $12.43 M(+10.1%) |
| Dec 2021 | $11.28 M(+13.0%) | $2.56 M(+0.6%) | $11.28 M(+0.5%) |
| Sep 2021 | - | $2.55 M(-17.0%) | $11.23 M(+2.7%) |
| Jun 2021 | - | $3.07 M(-1.2%) | $10.93 M(+8.4%) |
| Mar 2021 | - | $3.10 M(+23.9%) | $10.09 M(+1.0%) |
| Dec 2020 | $9.99 M(-17.8%) | $2.50 M(+11.1%) | $9.99 M(-6.6%) |
| Sep 2020 | - | $2.26 M(+1.6%) | $10.69 M(-5.2%) |
| Jun 2020 | - | $2.22 M(-26.1%) | $11.28 M(-7.4%) |
| Mar 2020 | - | $3.00 M(-6.5%) | $12.17 M(+0.2%) |
| Dec 2019 | $12.15 M(+23.1%) | $3.21 M(+13.2%) | $12.15 M(+5.8%) |
| Sep 2019 | - | $2.84 M(-8.9%) | $11.49 M(-1.9%) |
| Jun 2019 | - | $3.12 M(+4.4%) | $11.71 M(+6.8%) |
| Mar 2019 | - | $2.98 M(+17.2%) | $10.97 M(+11.1%) |
| Dec 2018 | $9.88 M | $2.55 M(-17.0%) | $9.88 M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $3.07 M(+29.2%) | $8.83 M(+22.0%) |
| Jun 2018 | - | $2.37 M(+25.5%) | $7.24 M(+14.0%) |
| Mar 2018 | - | $1.89 M(+26.0%) | $6.35 M(+2.7%) |
| Dec 2017 | $6.19 M(+12.1%) | $1.50 M(+1.7%) | $6.19 M(+5.0%) |
| Sep 2017 | - | $1.48 M(-0.4%) | $5.89 M(+1.4%) |
| Jun 2017 | - | $1.48 M(-14.2%) | $5.81 M(+0.3%) |
| Mar 2017 | - | $1.73 M(+43.2%) | $5.79 M(+4.9%) |
| Dec 2016 | $5.52 M(+25.0%) | $1.21 M(-13.7%) | $5.52 M(-0.4%) |
| Sep 2016 | - | $1.40 M(-4.5%) | $5.54 M(+2.5%) |
| Jun 2016 | - | $1.46 M(+0.5%) | $5.41 M(+10.4%) |
| Mar 2016 | - | $1.46 M(+18.7%) | $4.90 M(+11.0%) |
| Dec 2015 | $4.41 M(+23.9%) | $1.23 M(-2.8%) | $4.41 M(+5.2%) |
| Sep 2015 | - | $1.26 M(+32.1%) | $4.20 M(+13.2%) |
| Jun 2015 | - | $954.90 K(-1.8%) | $3.71 M(-0.7%) |
| Mar 2015 | - | $972.10 K(-3.5%) | $3.73 M(+4.8%) |
| Dec 2014 | $3.56 M(+66.9%) | $1.01 M(+30.4%) | $3.56 M(+5.2%) |
| Sep 2014 | - | $772.50 K(-21.4%) | $3.39 M(+8.7%) |
| Jun 2014 | - | $982.60 K(+22.7%) | $3.12 M(+11.5%) |
| Mar 2014 | - | $800.60 K(-3.8%) | $2.79 M(+30.9%) |
| Dec 2013 | $2.13 M(+231.0%) | $832.40 K(+66.3%) | $2.13 M(+61.4%) |
| Sep 2013 | - | $500.40 K(-24.3%) | $1.32 M(+60.9%) |
| Jun 2013 | - | $660.60 K(+367.5%) | $822.20 K(+408.8%) |
| Mar 2013 | - | $141.30 K(+596.1%) | $161.60 K(+696.1%) |
| Dec 2012 | $644.90 K(-13.3%) | $20.30 K | $20.30 K |
| Dec 2011 | $743.90 K | - | - |
FAQ
- What is Aldeyra Therapeutics annual SGA?
- What is the all time high annual SGA for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual SGA year-on-year change?
- What is Aldeyra Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly SGA year-on-year change?
- What is Aldeyra Therapeutics TTM SGA?
- What is the all time high TTM SGA for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics TTM SGA year-on-year change?
What is Aldeyra Therapeutics annual SGA?
The current annual SGA of ALDX is $11.89 M
What is the all time high annual SGA for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual SGA is $15.37 M
What is Aldeyra Therapeutics annual SGA year-on-year change?
Over the past year, ALDX annual SGA has changed by -$1.44 M (-10.82%)
What is Aldeyra Therapeutics quarterly SGA?
The current quarterly SGA of ALDX is $1.95 M
What is the all time high quarterly SGA for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly SGA is $5.57 M
What is Aldeyra Therapeutics quarterly SGA year-on-year change?
Over the past year, ALDX quarterly SGA has changed by $0.00 (0.00%)
What is Aldeyra Therapeutics TTM SGA?
The current TTM SGA of ALDX is -$1.71 B
What is the all time high TTM SGA for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high TTM SGA is -$54.38 M
What is Aldeyra Therapeutics TTM SGA year-on-year change?
Over the past year, ALDX TTM SGA has changed by -$1.72 B (-14444.81%)